Exclusive
eye-light
IPL and photobiomodulation (LLLT) platform
Espansione's flagship light-therapy platform combines LM™ LLLT photobiomodulation and OPE™ IPL in one device. In the anterior segment it treats dry eye, meibomian gland dysfunction and other ocular-surface conditions and helps stabilise the tear film before and after surgery. In the posterior segment it uses red and yellow photobiomodulation to support retinal cell metabolism and slow the progression of dry AMD (AREDS 2–3).
Exclusive distributor for CZ & SK
Serviced by manufacturer-trained engineers. New devices include two years of free service – only the engineer's travel is charged.
Highlights
- Two technologies in one device: LM™ LLLT mask and OPE™ IPL applicator that needs no gel
- Red, blue and yellow LLLT light, each matched to its own indications
- Up to nine treatment protocols; new ones are added by software without replacing the device
- Posterior segment: retinal photobiomodulation for dry AMD (AREDS 2–3), 12-minute session
- 15-minute LLLT session that runs without the operator present
- 7″ touchscreen with on-screen guidance, configuration checks and safety alerts
Technical specifications
- Technology
- LM™ LLLT (photobiomodulation) + OPE™ IPL
- LLLT light
- red, blue, yellow
- IPL
- polychromatic, software-calibrated pulses; no coupling gel
- Applicators
- LLLT mask + IPL applicator
- Treatment protocols
- up to 9 (anterior and posterior segment)
- Posterior segment
- red 630 nm and yellow 590 nm light – dry AMD (AREDS 2–3), 12 min
- LLLT session
- 15 min
- Display
- 7″ touchscreen
- Operating system
- Linux-based
- CE (MDR) indications
- dry eye/MGD, blepharitis, chalazion, Demodex, rosacea, post-blepharoplasty, dry AMD
- Medical device risk class
- Class IIa
More in this category
